“…For Asian patients, higher prevalences have been reported compared to Afro-Americans and Caucasians (5)(6)(7)(8)(9)(10). Reports about clinical associations of anti-Rib-P antibodies are in part controversial, including disease activity (10)(11)(12)(13)(14)(15), neuropsychiatric symptoms (6,(16)(17)(18)(19)(20)(21)(22)(23), lupus nephritis (12,(24)(25)(26), hepatic involvement (26)(27)(28), skin manifestations (11), juvenile SLE (12,29), and others (1,30).…”